Upcoming Discipline Hearings

Due to the COVID-19 pandemic, there are no in-person Discipline Committee proceedings until further notice. Hearings are being re-scheduled in alternative formats (that is, electronic or written proceedings). The schedule below is therefore subject to change.

Please refer to the Discipline Committee’s Direction respecting Electronic and Written Proceedings for further information.

The College will endeavour to ensure that Discipline Committee hearings held by alternative means are nonetheless accessible to the public, unless otherwise stated. If you plan to attend, or for further information, please e-mail hearingsoffice@ocpinfo.com or phone 1-416-962-4861.

The College is committed to supporting accessibility and providing accessible formats and communication supports for persons with disabilities. If you would like to attend a discipline hearing and require accommodations, please contact us at accessibility@ocpinfo.com to make appropriate arrangements.

Hearing Dates: May 18, 2021, May 19, 2021, May 20, 2021,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Bannis, as dispensing pharmacist and/or Designated Manager at ADV-CARE Pharmacy in Markham, Ontario, and/or as sole director and shareholder of the corporate owner of ADV-CARE Pharmacy, committed professional misconduct with respect to over 25,000 orders filled for prescription drugs for patients in the U.S. authorized by physicians licenced in the U.S. but not in Canada, in or about January 2012-June 2017, in that she

  • Filled without valid authorization by a physician licensed in Canada or otherwise;
  • Filled on the basis of co-signed or rewritten prescriptions issued by physicians licensed in Canada contrary to the OCP policy, Prescription – Out of Province, dated January-February 2003; and/or
  • Filled contrary to the OCP policy, Operating Internet Sites, dated June 2001, in relation to:
    • dispensing prescription drugs without valid authorization,
    • failing to confirm the authenticity of the orders for prescription drugs,
    • failing to provide counselling to patients regarding the orders for prescription drugs, and/or
    • failing to maintain adequate and/or accurate records regarding the orders for prescription drugs

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required
  • Falsified a record relating to her practice
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular, sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all circumstances, would be regarded by members as disgraceful, dishonourable or unprofessional

A motion in this matter will be heard on April 29, 2021.

Hearing Dates: May 28, 2021,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Soutsada Vongsaly, as a pharmacy technician at Shoppers Drug Mart, located at 550 King Street North in Waterloo, Ontario (the “Pharmacy”), committed professional misconduct in that she knowingly entered a fraudulent narcotics prescription into the Pharmacy’s computer system on or about April 7, 2020.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, paragraph 11 (3) of the Narcotics Safety and Awareness Act, 2010;
  • Knowingly permitted the premises in which a pharmacy is located to be used for unlawful purposes, where such purposes may reasonably be regarded by members as likely to demean the integrity or dignity of the profession or bring the profession into disrepute;
  • Permitted, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, and in particular, paragraph 11 (3) of the Narcotics Safety and Awareness Act, 2010;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming of a member.

Hearing Dates: June 16, 2021,

Summary of Allegations

At a hearing on March 8, 2021, a Panel of the Discipline Committee made findings of professional misconduct against Felix Odigie, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at UniMed Dispensaries in Burlington, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, with respect to two referrals from the Inquiries, Complaints and Reports Committee, as follows.

Referral 1

The Panel found that Mr. Odigie committed professional misconduct in that:

  • Between about May 29, 2017 and April 18, 2018, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to patient [Patient 1] in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about May 29, 2017 and April 18, 2018, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to patient [Patient 1] in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about January 1, 2018 and July 17, 2018, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to patient [Patient 2] in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about January 1, 2018 and July 17, 2018, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to patient [Patient 2]. in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication.

In particular, the Panel found that he:

  • Failed to maintain a standard of practice of the profession;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

Referral 2

The Panel found that Mr. Odigie committed professional misconduct in that:

  • Between about January 1, 2018 and February 12, 2019, he practised the profession while in a conflict of interest, and in particular, he practised as dispensing pharmacist and/or Designated Manager at the Pharmacy, while the Pharmacy engaged in financial transactions with an individual ([Name]), who was authorized to give instructions to the Pharmacy’s bank(s) and who was authorized to and did sign cheques on the Pharmacy’s bank account(s), and while all or substantially all the Pharmacy’s patients were referred to the Pharmacy by [Name];
  • Between about January 1, 2018 and February 12, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to certain identified patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other reasonable basis;
  • Between about January 1, 2018 and February 12, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to certain identified patients on a daily basis, without an appropriate clinical, therapeutic, or other reasonable basis for dispensing daily;
  • Between about January 1, 2018 and February 12, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to certain identified patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other basis;
  • Between about January 1, 2018 and February 12, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to certain identified patients on a daily basis, without an appropriate clinical, therapeutic, or other reasonable basis for dispensing daily;
  • Between May 7, 2018 and May 11, 2020, he provided (or permitted, consented to or approved, expressly or impliedly, the provision of) false or misleading information to an Ontario College of Pharmacists investigator in the course of their investigation into his conduct, and/or he failed to cooperate with the investigator’s investigation into his conduct, including without limitation with respect to certain identified information, contrary to ss. 76(3) and/or 76(3.1) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991.

In particular, the Panel found that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular:
    • ss. 76(3) and/or 76(3.1) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

Submissions with respect to the Order to be imposed will continue on June 16, 2021.

Hearing Dates: July 7, 2021,

Summary of Allegations

Following a hearing held on February 11 to 14, 2020, February 20, 2020, and May 11, 2020, a Panel of the Discipline Committee made findings of professional misconduct against Salvatore Forcucci in a decision dated January 12, 2021, in that he:

  • Provided benzodiazepines to [Name] without a prescription, or without evidence of a prescription, on one occasion;
  • Interfered with [Name]’s medication management by:
    • On one occasion, providing [Name] with medication:
      • that had been prescribed to another individual; and/or
      • or which he did not have evidence of a prescription; and/or
      • that was contrary to the advice provided by [Name]’s other health care providers
  • Made disparaging and inappropriate comments to [Name] a patient or former patient about pharmacy students employed by the Pharmacy.

In particular, the Panel found that he:

  • Contravened a federal law with respect to the distribution, purchase, sale or dispensing or prescribing of any drug, and in particular, s. 5(1) of the Controlled Drugs and Substances Act, SC 1996, s 19, and s. 51 of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
  • Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as dishonourable and unprofessional

Submissions with respect to the order to be made will be heard on July 7, 2021.

Hearing Dates: July 12, 2021, July 15, 2021, July 16, 2021, July 23, 2021, August 23, 2021,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Awad, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at John Garland Pharmacy (the “Pharmacy”) in Etobicoke, Ontario, committed professional misconduct in that she

  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017; and/or
  • Submitted an account or charge for services that she knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients and/or practice
  • Falsified a record relating to her practice and/or a person’s health record
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40(1) and 54(1) of Ontario Regulation 58/11
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40 and 54(1) of Ontario Regulation 58/11
    2. sections 5, 6, and 15(1) of the Ontario Drug Benefit Act and section 27 of Ontario Regulation 201/96
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Note: this hearing commenced September 14-18, 2020.

Hearing Dates: September 28, 2021, September 29, 2021, September 30, 2021,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sameh Sadek, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at MD Health Pharmacy in Brampton, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

  • He failed to report to the Registrar the details of being charged on or about February 22, 2017 with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
  • He failed to report to the Registrar the details of being charged on or about March 27, 2018 with the offence of assaulting a peace officer contrary to s. 270(1)(a) of the Criminal Code of Canada;
  • On or about March 8, 2018, he declared to the College as part of his annual renewal process that he was not currently charged with a criminal offence or any other offence in Ontario or any other jurisdiction, when at that time he was charged with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
  • Between about June 1, 2017 and February 20, 2018, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) claims, charges and/or accounts for drugs that were not dispensed, and/or that were for invalid prescriptions, with respect to certain identified drugs;
  • On or about April 27, 2018 and in the period following that date, he closed the Pharmacy without complying with the requirements for closing a Pharmacy, and in particular:
    • he failed to remove all signs and symbols relating to the practice of pharmacy from within and outside the premises;
    • he failed to remove and dispose of all drugs according to law;
    • he failed to submit to the Registrar a Pharmacy Closing Statement;
    • he failed to deliver prescription records;
    • he failed to ensure the Pharmacy’s records were maintained in a secure manner and for the required period of time;
  • On or about June 13, 2018, July 4, 2018, and July 19, 2018, he failed to reply within a reasonable time to requests from the College relating to the closure of the Pharmacy.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation on his certificate of registration;
  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular:
    • s. 141 and s. 157(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
    • ss. 20(2) and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
  • Failed to reply within a reasonable time to a written or electronic inquiry or request from the College;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe committed professional misconduct in that she:

  • Failed to fulfill all requirements related to working with a practice mentor, as ordered by the Discipline Committee on December 8, 2016.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe, while practising as a pharmacist, Designated Manager and/or the sole director and shareholder of the corporation that owned and operated Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario, committed professional misconduct in that she

  • Engaged in the practice of pharmacy while her certificate was suspended from on or around December 1, 2018 to on or around January 31, 2019;
  • Falsified records relating to her practice or a person’s health record with respect to one or more identified prescriptions from on or about December 1, 2018 to on or about January 31, 2019;
  • Kept medications in inventory without expiration dates and/or lot numbers, in or around February of 2019.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Practised the profession while her certificate was under suspension;
  • Falsified records relating to her practice or a person’s health record;
  • Failed to maintain a standard of practice of the profession;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Joy Abanzukwe, as a dispensing pharmacist and/or Designated Manager at Remedy’s Rx Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario (the Pharmacy), and/or as the director and/or sole shareholder of the corporation that owned the Pharmacy, committed professional misconduct with respect to the following:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totalling approximately $103,932 for 20 identified drug and other health products, from on or around July 1, 2015 to on or around August 31, 2017; and/or
  • Improper claims for prescriptions submitted to the ODB from the Pharmacy totalling approximately $19,485, in relation to one or more of certain identified claims.

In particular, it is alleged that she:

  • Failed to maintain a standard of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 5, 15, 17 and/or 23 of the Ontario Drug Benefit Act; and/or
    • sections 25 and/or 27 of Ontario Regulation 201/96; and/or
    • sections 155, 156, 163 and/or 166 of the Drug and Pharmacies Regulation Act;
  • Failed to keep records as required respecting her patients;
  • Submitted an account or charge for services that she knew and/or ought to have known was false or misleading;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document she knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Joy Abanzukwe, as a dispensing pharmacist and/or Designated Manager at Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario (the Pharmacy), and/or as the director and/or sole shareholder of the corporation that owned the Pharmacy, committed professional misconduct in that she:

  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products, from on or around January 1, 2019 to on or around December 31, 2019;
  • Falsified a record relating to her practice or a person’s health record with respect to one or more of certain identified drugs and/or products, from on or around January 1, 2019 to on or around December 31, 2019;
  • Signed or issued, in her professional capacity, a document she knew or ought to have known contained a false or misleading statement, with respect to one or more of certain identified drugs and/or products, from on or around January 1, 2019 to on or around December 31, 2019; and/or
  • Failed to maintain the integrity the Pharmacy’s inventory of zopiclone, resulting in the loss of approximately 836 7.5 mg tablets of zopiclone medications, from approximately January 1, 2018 to August 12, 2020.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
  • Falsified a record relating to her practice or a person’s health record;
  • Signed or issued, in her professional capacity, a document she knew or ought to have known contained a false or misleading statement;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Accreditation Committee, it is alleged that 2037424 Ontario Inc., to whom the certificate of accreditation for Brock Medical Pharmacy was issued, and Joy Abanzukwe, the sole director of 2037424 Ontario Inc. and the Designated Manager of Brock Medical Pharmacy, committed an act or acts of proprietary misconduct by refilling, selling and/or renewing prescription drugs without a prescription, between in or around April 11, 2019 and July 17, 2019.

In particular, it is alleged that 2037424 Ontario Inc., to whom the certificate of accreditation for Brock Medical Pharmacy was issued, and Joy Abanzukwe, the sole director of 2037424 Ontario Inc. and the Designated Manager of Brock Medical Pharmacy:

  • Contravened the Drug and Pharmacies Regulation Act, the Pharmacy Act, 1991, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act, the Ontario Drug Benefits Act or the regulations under those Acts, including but not limited to section 155 of the Drug and Pharmacies Regulation Act;
  • Contravened a federal, provincial or territorial law or any municipal by-law, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug product, the administering of any substance or the piercing of the dermis, where the purpose of the law or by-law is to protect or promote public health, or where the law or bylaw relates to the operation of the pharmacy or the provision of pharmacy services, including but not limited to subsection C.01.041(1)(a) of the Food and Drug Regulations, C.R.C., c. 870, as amended; and
  • Engaged in conduct or performed an act relevant to the operation of a pharmacy that, having regard to the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading;
  • Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
  • Charged (or permitted, consented to, or approved, expressly or by implication, charges for) a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario committed professional misconduct, in that he:

  • Provided falsified employment records and/or other pharmacy records to the College;
  • Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
  • Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

  • Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
    • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nekpen Asemota, as pharmacist and Designated Manager at Shoppers Drug Mart, located at 1675 Wyandotte Street West, in Windsor, Ontario (the Pharmacy), and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that she:

  • Failed to ensure that the Pharmacy had adequate protocols and policies in place to verify the contents of compliance package medication dispensed from the Pharmacy, from on or about January 2018, to on or about November 20, 2018;
  • Failed to ensure the Pharmacy had adequate protocols and policies in place to record and reconcile medication inventory, including medication that had been returned to stock from compliance packages, from on or about January 2018, to on or about November 20, 2018;
  • Failed to complete inventory reconciliations for narcotics and other controlled drugs at least every six months, and/or failed to retain records of such inventory reconciliations, from on or about May 5, 2017, to on or about November 20, 2018;
  • Maintained incomplete and/or inaccurate records with respect to compliance pack medication for certain identified patients, from on or about January 2018, to on or about November 20, 2018;
  • Billed for the dispensing of medication in compliance aids to patients on dates when compliance aids were not dispensed, with respect to certain identified patients, from on or about January 2018, to on or about October 2018;
  • Permitted, consented to or approved, either expressly or by implication, an unregistered Pharmacy assistant to bear a name-tag falsely identifying her with the protected title “Pharmacy Technician”, on or about November 20, 2018.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients or practice;
  • Falsified a record related to her practice or a person’s health record;
  • Signed or issued in her professional capacity, a document that she knew or ought to have known contained a false a misleading or statement;
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Robert Awad, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Aim Drug Mart in London, Ontario, committed professional misconduct in that:

  • At various times between about January 1, 2015 and June 10, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to Rebif 132mcg Multi-Dose;
  • At various times between about October 20, 2017 to February 11, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to intra-nasal Naloxone Kit (2), DIN 93877256;
  • At various times between about January 1, 2015 and December 31, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions that had been billed to the Ontario Drug Benefit program and that required a manual submission to ensure the reversal of the charge, without completing the manual submission, or ensuring that it was done, and therefore without ensuring the reversal of the charge.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice and/or to a person’s health record;
  • Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
  • Charged a fee that was excessive in relation to the service or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amani Awad committed professional misconduct in that she:

  • Attempted to bribe, interfere, obstruct, threaten, and/or tamper with one or more witnesses in a hearing before the Discipline Committee of the Ontario College of Pharmacists regarding allegations of professional misconduct against her.

In particular, it is alleged that she:

  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional;
  • Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, as Designated Manager and sole director and shareholder of the corporation that owned and operated Shoppers Drug Mart, located on 1821 Robertson Road in Ottawa, Ontario, committed professional misconduct in that he:

  • Maintained prescription hardcopies that were missing pharmacist signatures in respect of approximately 1267 transactions, from on or about 2015, to on or about September 10, 2018; and/or
  • Completed pharmacist-authorized prescription renewals for controlled substances that he did not have the authority to renew in respect of approximately 48 transactions, from on or about January 1, 2017, to on or about September 7, 2018; and/or
  • Completed pharmacist-authorized prescription renewals for which he maintained incomplete or insufficient documentation in respect of approximately 352 transactions, from on or about July 22, 2016, to on or about June 21, 2018; and/or
  • Submitted bills for MedsChecks transactions which he did not complete in respect of:
    1. 44 MedsChecks billed on September 26, 2016; and/or
    2. 28 MedsChecks billed on September 30, 2016; and/or
    3. 26 MedsChecks billed on December 28, 2017; and/or
  • Failed to properly maintain MedsChecks documentation as required in respect of:
    1. 44 transactions billed on or about September 26, 2016; and/or
    2. 28 transactions billed on or about September 30, 2016; and/or
    3. 26 transactions billed on or about December 28, 2017; and/or
    4. 40 transactions billed from on or about February 17, 2017, to on or about August 11, 2018; and/or
    5. 12 MedsChecks Patient Acknowledgement Forms which were inaccurately dated or undated; and/or
  • Failed to document notification of, and/or notify patients’ primary care providers as required, with respect to 51 MedsChecks transactions, from on or about October 1, 2016, to on or about September 10, 2018; and/or
  • Failed to document notification of, and/or notify patients’ prescribers as required, with respect to 403 pharmacist-authorized prescription renewals, from on or about January 1, 2016, to on or about September 10, 2018; and/or
  • Failed to document notification of, and/or notify the prescriber of patient [Name], as required, with respect to 18 pharmacist-authorized prescription renewals, from on or about December 4, 2017, to on or about April 2, 2018.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients;
  • Falsified a record related to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, committed professional misconduct in that he:

  • Failed to report to the College that he had been charged with a criminal offence (having care and control of a motor vehicle while “over 80”, contrary to section 253(1)(b) of the Criminal Code) on May 22, 2013, and/or that he had been convicted of that offence on May 29, 2014;
  • On his annual renewal form submitted on or about March 5, 2014, he falsely answered “no” on his 2014 College Annual Renewal Form, to the question “are you the subject of a current proceeding in respect of any offence in any jurisdiction?”; and/or on his annual renewal form submitted on or about March 9, 2015, he falsely answered “no” on no 2015 College Annual Renewal Form, to the question “since your last declaration to the College, have you been found guilty of any offence in any jurisdiction?”

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Signed or issued, in his professional capacity, a document that the he knew contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that David Bedggood, in his role as pharmacist, Designated Manager, director and/or shareholder at FYP Pharmacy, and/or in his role with [Entity], committed professional in relation to:

  • Deliveries of prescription drugs to FYP Pharmacy in the absence of a pharmacist and/or to individuals who were not pharmacists and/or employees of FYP Pharmacy;
  • The ongoing activities of FYP Pharmacy when it was not entitled to operate from August 10, 2018 through October 2018;
  • Failure to comply with the interim order of the Accreditation Committee of the College made in September 2018;
  • The sale of medications from [Entity] to [Pharmacy]; and/or
  • Failure to respond to communications from the College’s investigator.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to subsection 146(1)(a) of the Drug and Pharmacies Regulation Act;
  • Contravened any federal, provincial or territorial law or municipal by-law, i. with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, ii. whose purpose is to protect or promote public health, or iii. that is otherwise relevant to the member’s suitability to practise, in particular but not limited to the Food and Drugs Act, R.S.C., 1985, c. F-27, and the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs;
  • Failed to reply within a reasonable time to a written or electronic inquiry or request from the College;
  • Failed to comply with an order of a Committee or a panel of a Committee of the College;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dumfour David Berko, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at the […] Pharmacy in […], Ontario, in the period from about [Identified Date A] to [Identified Date B], committed professional misconduct in that he:

  • Sexually abused a patient, […]
  • Failed to maintain appropriate professional boundaries with a patient, […]
  • Provided a scheduled drug (Tylenol #3) to a patient, […], without a validly authorized prescription.

In particular, it is alleged that he:

  • Sexually abused a patient;
  • Failed to maintain a standard of practice of the profession;
  • Contravened s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, specifically s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

A motion in this matter was heard on April 27, 2021.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dejan Buric, as a dispensing pharmacist and/or Designated Manager at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor (the Pharmacy), committed professional misconduct with respect to the following:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy from approximately February 1, 2016 to approximately August 22, 2017 for seven identified drugs, or any of them; and/or
  • Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy in relation to one or more of certain identified claims.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 5, 15, 17 and/or 23 of the Ontario Drug Benefit Act and/or;
    • sections 18, 25 and 29(1) of Ontario Regulation 201/96, and/or;
    • section 166 of the Drug and Pharmacies Regulation Act;
  • Failed to keep records as required respecting his patients;
  • Falsified a record relating to his practice;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alexander Chan, while practising pharmacy as a staff pharmacist and owner at [the Pharmacy], committed professional misconduct in that:

  • On or about [date], he sexually assaulted a volunteer at the Pharmacy, [Name];
  • On October 15, 2020, he was found guilty of sexual assault contrary to section 271 of the Criminal Code of Canada.

In particular, it is alleged that he:

  • Was found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct that is unbecoming of a Member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alexander Chan, while practising pharmacy as a staff pharmacist and owner at [the Pharmacy], committed professional misconduct in the period of [specified date ranges], in that he:

  • Made unwelcome comments of a sexual nature towards his co-worker and employee, [Co-Worker]; and/or
  • On one or more occasions, he touched inappropriately or attempted to touch inappropriately his co-worker and employee, [Co-Worker].

In particular, it is alleged that he:

  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming of a Member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amin Dharamsi, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at [the Pharmacy], and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct with respect to the following incidents:

  • Between about October 2, 2018 and January 23, 2019, he failed to take appropriate steps to ensure the destruction of narcotics, controlled drugs, and/or targeted substances;
  • On at least one occasion between about October 2, 2018 and January 23, 2019, he asked staff member [Person A] to destroy narcotics, controlled drugs, and/or targeted substances in his absence and/or in a manner contrary to Health Canada’s guidelines for the destruction of narcotics, controlled drugs, and/or targeted substances;
  • On one occasion between about October 2, 2018 and January 23, 2019, he removed narcotics, controlled drugs, and/or targeted substances from the Pharmacy’s premises without appropriate documentation and/or justification;
  • Between about October 2, 2018 and January 23, 2019, he provided routine pharmaceutical care and/or dispensed prescriptions to himself and to family members;
  • On multiple occasions between about October 2, 2018 and January 23, 2019, he attempted to create false and/or misleading pharmacy records by attempting to imitate the signature of another pharmacist on dispensing records, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
  • On or about November 1, 2018, he attempted to create false and/or misleading pharmacy records showing the dispensing of medication to patient [Patient 1] at a greater frequency than was actually dispensed, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
  • On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to dispense, and/or to assist in the dispensing of, drugs without the markings on the container required by s. 156(3) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
  • On at least two occasions between about October 2, 2018 and February 8, 2019, he gave previously-dispensed drugs and/or products to members of the Pharmacy’s staff and asked that they return the drugs and/or products to the Pharmacy’s inventory for resale;
  • On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, frequency of dispensing forms, and in particular with respect to falsifying the date on which the forms were sent to prescribers;
  • On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, the Pharmacy’s records relating to documenting the calibration of the Pharmacy’s scale and/or the temperature of the Pharmacy’s refrigerator;
  • On multiple occasions between about [specified date A] and [specified date B], he behaved inappropriately toward and/or in the presence of members of the Pharmacy’s staff, including with respect to the following:
    1. he raised his voice, and/or threw objects, and/or shouted, at members of the Pharmacy’s staff;
    2. he hugged and/or kissed staff member [Person B];
    3. he asked staff member [Person B] inappropriately personal questions;
    4. he harassed staff members[ Person B] and [Person A] by persistently contacting them outside of their working hours at their personal contact numbers and/or email addresses;
  • On at least one occasion between about October 2, 2018 and January 23, 2019, he practised the profession while his ability to do so was impaired or adversely affected by a substance, condition, dysfunction, disorder or circumstance, including but not limited to Nabilone and/or Suboxone;
  • On multiple occasions between about October 2, 2018 and January 23, 2019, including on December 18, 2018, December 20, 2018, and/or January 4, 2019, he referred to himself by the title “Doctor” or an abbreviation thereof, and/or he represented himself as holding the educational degree of Doctor of Pharmacy by using the abbreviation “Pharm. D” after his name, without justification or authority;
  • Between about October 2, 2018 and January 23, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other reasonable basis;
  • Between about October 2, 2018 and January 23, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other basis.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while his ability to do so was impaired or adversely affected by any substance, condition, dysfunction, disorder or circumstance that he knew or ought to have known would impair or adversely affect his ability to practice;
  • Inappropriately used a term, title or designation in respect of his practice;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professionals Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular s. 33(1) of the Regulated Health Professions Act, 1991, SO 1991, c 18;
  • Contravened a federal, provincial, or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular s. 43 of the Narcotic Control Regulations, CRC, c 1041;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Rabeb, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading statement;
  • Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
  • Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Raheb, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Provided falsified employment records and/or other pharmacy records to the College;
  • Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
  • Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

  • Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
    • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shereen El-Azrak committed professional misconduct in that

  • On September 25, 2018, in the Superior Court of Justice at Newmarket, she was found guilty of trafficking in fentanyl and possession of fentanyl for the purpose of trafficking, contrary to s. 5 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19.

In particular, it is alleged that she

  • Was found guilty of offences that are relevant to her suitability to practice.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Albair Faltas, while he was a pharmacist, as well as a director and shareholder of the owner of Huron Village Pharmacy in Kitchener, Ontario (the “Pharmacy”), committed professional misconduct, as follows:

  1. On more than one occasion between at least January 2019 and September 2020, he failed to carry out or abide by the terms of an undertaking he gave to the College, dated January 31, 2019, including by:
    1. Practising pharmacy without the supervision of a pharmacist listed in Part A of the College’s Register who was physically present on the Pharmacy premises at all times while he was working; and/or
    2. Failing to notify the College of the name of each pharmacist who was supervising him prior to continuing practise in the Pharmacy;
  1. On more than one occasion between at least January 2019 and September 2020, he contravened the Drug and Pharmacies Regulation Act (DPRA), including by:
    1. Permitting, consenting to or approving, either expressly or by implication, the operation of the Pharmacy while it was not managed by a Designated Manager, contrary to s. 146(1)(b) of the DPRA; and/or
    2. Permitting, consenting to or approving, either expressly or by implication, the failure of the owner of the Pharmacy to designate a Designated Manager for the Pharmacy, and file notice of the designation with the College in accordance with the regulations, contrary to s. 146(1.1) of the DPRA;
  1. In or around June 2020, he attempted on behalf of the owner of the Pharmacy to designate himself as Designated Manager of the Pharmacy, even though he knew or ought to have known that he was bound by an undertaking he had given to the College not to be the Designated Manager of a pharmacy.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Contravened the Drug and Pharmacies Regulation Act;
  • Failed to carry out or abide by an undertaking given to the College;
  • Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Gerges, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Totten Pharmacy in Windsor, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Jimmy’s Pharmacy in Toronto, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pacific Pharmacy in Toronto, Ontario committed professional misconduct in that he:

  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for drugs and/or products that were never dispensed for one or more of certain identified drugs and/or products;
  • Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) pharmacy records regarding one or more of certain identified drugs and/or products;
  • Forged (or permitted, consented to or approved, expressly or by implication, the forgery of) prescriptions using a stolen prescription pad to support charges for one or more of certain identified drugs/and or products;
  • Failed to keep records as required regarding one or more of certain identified drugs and/or products; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for approximately 755 claims for drugs, products, and/or fees in excess of the allowable amounts and/or markups permitted by [Claims Adjudicator].

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services and/or products that he knew and/or ought to have known was false or misleading;
  • Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee to patient [Name] in relation to her prescription for Nabilone 0.5mg/ml

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee in relation to the prescription of patient [Name] for Ziprasidone 15mg;
  • Failed to inform the parents of patient [Name] of less expensive ways in which the same medication could be prepared

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Maged Hanna, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at 3M Drug Mart (the “Pharmacy”) in Thornhill, Ontario, committed professional misconduct in that he:

  1. Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false or misleading with respect to:
    1. one or more of certain identified drugs and/or; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  2. Falsified a record relating to his patients and/or his practice with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  3. Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  4. Failed to keep records as required respecting his patients and/or his practice with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program;
  5. Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs with respect to:
    1. one or more of certain identified drugs and/or products; and/or
    2. one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or his practice;
  • Falsified a record relating to his patients and/or his practice;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • section 15 of the Ontario Drug Benefit Act;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about August 2014 to February 2018, committed professional misconduct in that he:

  • Failed to keep records as required by the College’s Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs;
  • Directed non-pharmacist employees to dispense methadone to patients;
  • Misappropriated prescription drugs and/or controlled substances from the pharmacy, including:
    • Oxycocet;
    • Tylenol #3 and/or Ratio-Lenoltec #3;
    • Clonazepam; and/or
    • Tramadol.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required;
  • Contravened s. 149(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically
    • s. 4 of the Controlled Drugs and Substances Act;
    • s. 51(1) of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
    • s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about December 2015 to April 2019, committed professional misconduct in that he:

  • Failed to report to the Registrar that he had been charged criminally with offences under the Controlled Drugs and Substances Act on or about December 24, 2015;
  • Unlawfully possessed the following controlled substances without a prescription when stopped by police in King Township, Ontario on December 24, 2015:
    • Oxycontin;
    • Oxycocet;
    • Oxycodone; and/or
    • Morphine.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Failed to maintain a standard of practice of the profession;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically:
    • s. 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shamez Kassam, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Chapmans Pharmacy in London, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following:

  • At various times between about February 2010 and June 12, 2019, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, including:
    1. by instructing staff (or permitting, consenting to or approving, expressly or impliedly, the instruction to staff) to not cancel prescriptions that had been billed but not dispensed to patients, and/or
    2. with respect to certain identified drugs and/or;
  • Between about October 1, 2017 and November 30, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions for which the Pharmacy was not entitled to payment, without taking the steps (or ensuring the steps were taken) that were necessary to ensure the reversal of the charges billed by the Pharmacy, with respect to certain identified prescriptions;
  • Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program for which he was required to have and maintain records that he did not have and/or maintain;
  • Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program and accepted payment for those claims without being entitled to payment;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to dispense methadone and/or Suboxone to patients without a pharmacist present to witness the patient’s dose, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to dispense prescription medication to patients without ensuring that a pharmacist or registered pharmacy technician had verified the prescription and its preparation, and had signed the prescription hardcopy, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to sign prescription hardcopies in a manner intended to or that he ought reasonably to have expected would be confused for a pharmacist’s signature, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about May 27, 2014 and June 12, 2019, he failed to ensure appropriate staffing levels in the Pharmacy to enable himself and other staff to maintain the accepted standard of pharmacy practice and to deliver safe and effective patient care;
  • Between about December 2016 and February 2017, he instructed staff to dispense reconstituted powdered methadone to patients while billing those patients’ prescriptions as though Methadose had been dispensed, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • Between about January 1, 2016 and December 31, 2018, he failed to report (or ensure the reporting of) a loss or theft of narcotics relating to losses of Hydromorph contin 18mg, 24mg, and/or 30mg, as required by s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
  • Between about January 1, 2016 and June 12, 2019, he failed to ensure that inventory reconciliations of narcotics and controlled/targeted substances were performed at least every six months and/or with reasonable/required frequency.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients or practice;
  • Falsified a record relating to his practice and/or to a person’s health record;
  • Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • s. 156(1)(g) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
  • Contravened a federal or provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or mixture of drugs or product, and in particular:
    • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, RSO 1990, c O.10, as amended;
    • s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Khan, while engaged in the practice of pharmacy as a dispensing pharmacist at Shoppers Drug Mart, located at 300 Taunton Road East in Oshawa (“SDM Taunton”) and/or at Shoppers Drug Mart located at 20 Warren Road in Oshawa (“SDM Warren”), committed professional misconduct in that she

  • Was found guilty of an offence that is relevant to her suitability to practise with respect to findings of guilt made on December 18, 2017, by the Ontario Court of Justice at Oshawa in relation to the following counts:
    • Theft of Oxycocet exceeding $5,000, contrary to section 334(a) of the Criminal Code of Canada;
    • Fraud with respect to Oxycocet exceeding $5,000, contrary to section 380(1)(a) of the Criminal Code of Canada;
    • Theft of Oxycocet not exceeding $5,000, contrary to section 334(b) of the Criminal Code of Canada; and/or
    • Fraud with respect to Oxycocet not exceeding $5,000, contrary to section 380(1)(b) of the Criminal Code of Canada;
  • In the period from in or about February 17, 2017, to April 29, 2017, she misappropriated at least 11,830 tablets of Ratio-Oxycocet and/or Sandoz-Oxycodone Acetaminophen, without authorization or record, from SDM Taunton;
  • In the period from in or about April 5, 2016, to December 10, 2016, she misappropriated at least 78,045 tablets of Ratio-Oxycocet, without authorization or record, from SDM Warren;
  • In the period from in or about February 17, 2017, to April 29, 2017, she submitted approximately 28 false claims, for which there were no valid prescriptions and for which payment was not required, to the Ontario Drug Benefit program (“ODB”) from SDM Taunton; and/or
  • In the period from in or about April 5, 2016, to December 10, 2016, she submitted approximately 304 false claims, for which there were no valid prescriptions and for which payment was not required, to the ODB from SDM Warren.

In particular, it is alleged that she

  • Was found guilty of an offence that is relevant to her suitability to practice;
  • Failed to maintain a standard of practice of the profession;
  • Dispensed or sold drugs for an improper purpose;
  • Failed to keep records as required respecting her patients;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • Section 155 of the Drug and Pharmacies Regulation Act
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • Sections C.01.041, G.03.002, and/or G.03.012 of the Food and Drug; Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S,C. 1985, c. F-27, as amended;
    • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 31 of the Narcotic Control Regulations, C.R.C., c. 1041, as amended, to the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, as amended, and the Notice issued thereunder, and/or section 11 of the Narcotic Safety and Awareness Act, 2010, S.O. 2010 C.22, as amended;
    • Section 15 of the Ontario Drug Benefit Act, R.S.O. 1990, C.0.10, as amended;
    • Sections 334(a), 334(b), 380(1)(a), and/or 380(1)(b) of the Criminal Code of Canada;
  • Knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Seema Khan, while she employed as a dispensing pharmacist, committed professional misconduct in that she:

  • Failed to maintain the professional boundaries of the pharmacist-patient relationship when she engaged in a non-professional, personal relationship with the patient, [Name], from in or about [Specified Date 1] to in or about [Specified Date 2]; and/or
  • Engaged in sexual abuse of the patient, [Name], on one or more occasions, from in or about [Specified Date 1] to in or about [Specified Date 2].

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Sexually abused a patient;
  • Abused a patient verbally or physically;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shoukry Koussa committed professional misconduct in that he:

  • Failed to report to the College’s Registrar, four charges laid against him pursuant to the Criminal Code of Canada on April 21, 2018, as required by Section 5, paragraph 1 of Ontario Regulation 202/94 under the Pharmacy Act, 1991, within 30 days as required by College By-Laws, from on or about May 21, 2018, to on or about March 10, 2019;
  • Failed to report to the College’s Registrar, two guilty findings made against him under the Criminal Code of Canada on September 3, 2019, as required by Section 5, paragraph 1 of Ontario Regulation 202/94 under the Pharmacy Act, 1991, within 30 days as required by College By-Laws, from on or about October 3, 2019, to on or about March 3, 2020, and/or as soon as reasonably practicable after receiving notice of the findings of guilt as required by section 85.6.1 of the Health Professions Procedural Code, being Schedule 2 of the Regulated Health Professions Act, 1991, from on or about September 3, 2019, to on or about March 3, 2020;
  • Committed two counts of assault, contrary to section 266 of the Criminal Code of Canada, on or about April 21, 2018, resulting in his third time being found criminally guilty for this charge;
  • Knowingly uttered a threat to cause death, contrary to section 264.1(1) (a) of the Criminal Code of Canada, on or about April 21, 2018, resulting in a guilty finding for this charge.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Contravened the Regulated Health Professions Act, 1991, and/or a regulation under the Pharmacy Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christine Martin, while employed as a pharmacy technician at Canadian Drug Mart in Barrie, committed professional misconduct in that she:

  • Misappropriated narcotics, contrary to Section 4(1) of the Controlled Drugs and Substances Act, S.C. 1996, from on or about October 2018, to on or about January 28, 2019; and/or
  • Falsified records with respect to the Pharmacy’s narcotics inventory, from on or about October 2018, to on or about January 28, 2019.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record related to her practice;
  • Contravened section 4(1) of the Controlled Drugs and Substances Act, S.C. 1996;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christine Martin committed professional misconduct in that:

  • On or about December 24, 2020, she was found guilty of two counts of knowingly using a forged narcotic prescription, contrary to section 368(1)(a) of the Criminal Code of Canada;
  • Obtained hydromorphone using fraudulent prescriptions on approximately thirty occasions from on or about December 3, 2018, to on or about July 10, 2019.

In particular, it is alleged that she:

  • Has been found guilty of an offence that is relevant to her suitability to practise;
  • Contravened sections 4(1) and 4(2)(a) of the Controlled Drugs and Substances Act, S.C. 1996;
  • Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Bichoy Maurice, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
  • Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
    • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
    • section 166 of the Drug and Pharmacies Regulation Act;
  • Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mina Michael, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
  • Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
    • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
    • section 166 of the Drug and Pharmacies Regulation Act;
  • Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that David Morkos, as dispensing pharmacist and/or Designated Manager at Woodgreen Pharmacy at 101 – 69 Queen Street East in Toronto, Ontario (the Pharmacy), and/or as a shareholder of the corporation that owned the Pharmacy, in the period from about March 2019 to September 2020, while engaged in the practice of pharmacy in the Province of Ontario, committed professional misconduct in that he:

  • Failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs, including with respect to expired and/or unserviceable controlled substances;
  • Failed to maintain the security of narcotics and other controlled drugs, including expired and/or unserviceable substances;
  • Failed to maintain accurate records of purchases, sales and remaining inventory for narcotics and other controlled drugs;
  • Failed to complete inventory reconciliations for narcotics and other controlled drugs at least once every six months, and/or failed to retain complete records of such inventory reconciliations, in 2018, 2019 and/or 2020; and/or
  • Failed to make timely reports of losses of narcotics and other controlled drugs to Health Canada with respect to reconciliations conducted in 2018, 2019, and/or 2020.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required with respect to his patients or practice;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, including:
    • the Narcotic Control Regulations, sections 40, 42, and/or 43 under the Controlled Drugs and Substances Act, S.C. 1996, c 19, and/or
    • the Food and Drug Regulations, sections G.03.010, G.03.012, and/or G.03.013 under the Food and Drug Act, R.S.C. 1985 c.F-27, and/or
    • ss. 72 and 75 of the Benzodiazepines and Other Targeted Substances Regulation;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
  • Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
  • Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Practised the profession while he was in a conflict of interest
  • Failed to keep records as required respecting his patients
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

  • Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
  • Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Mourid, while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist at St. Mary Pharmacy, Ontario (“the Pharmacy”) committed professional misconduct in that she

  • Submitted and/or permitted, consented to or approved, either expressly or by implication, the submission of, accounts or charges for services that she knew were false or misleading to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of pharmacy records relating to her practice in relation to the dispensing of and/or claims made to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Failed to ensure that the Pharmacy complied with all legal requirements, including but not limited to, requirements regarding record keeping, documentation, and billing the Ontario Drug Benefit Plan.
  • Failed to keep records of monthly Ontario Drug Benefit eligibility cards or a copy of the cards with respect to each person for whom a drug was dispensed, as required by section 29 of Ontario Regulation 201/96, under the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, from on or about October, 2014 to on or about June, 2016
  • Submitted to the Ontario College of Pharmacists and/or the Ministry of Health and Long Term Care invoices, receipts and/or other documentation that she knew, or ought to have known, was false, misleading or unreliable to substantiate the purchase and/or transfer of one or more of certain identified drugs and/or products

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of records relating to her practice
  • Signed or issued, in her professional capacity, and/or permitted, consented to or approved, either expressly or by implication, the signing or issuing of a document that she knew contained a false or misleading statement
  • Submitted and/or permitted, consented to or approved the submission of accounts or charges for services that she knew to be false or misleading
  • Contravened the Pharmacy Act,1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts and in particular:
    1. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Permitted, consented to or approved, either expressly or by implication, the contravention of a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regarding to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

This hearing commenced on July 22, 2020.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Abdulmalik Premji, while practising pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Bay Ridges Pharmacy in Pickering, Ontario, in the period from about October 2018 to July 2019, committed professional misconduct in that he

  • Practised while in a conflict of interest with respect to patient [Name]; and/or
  • Failed to maintain the professional boundaries of the pharmacist-patient relationship with respect to patient [Name].

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jack (Mark) Rosenhek, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Markie Pharmacy in Toronto (the “Pharmacy”), in the period from about January 2018 to June 2019, while engaged in the practice of pharmacy in the Province of Ontario, committed professional misconduct in that he:

  • Failed to maintain accurate records with respect to the provenance and/or purchases of certain identified products;
  • Failed to ensure that prescription medications obtained for sale were of acceptable standard and quality, with respect to certain identified products;
  • Failed to ensure that prescription medications in stock were properly labelled, with respect to certain identified products.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Dispensed, sold or compounded a drug that he knew or ought to have known was not of good quality or did not meet the standards required by law;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alice Rusli, in her role as pharmacist, Designated Manager and/or shareholder at Glen Shields Pharmacy, committed professional with respect to the Pharmacy’s system and practices for obtaining veterinary drugs and/or products from [Wholesaler] through [Animal Hospital], including but not limited to in or around March 2019 through June 2019.

In particular, it is alleged that she:

  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement;
  • Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, and in particular section 33(2)(d) of the General Regulation, R.R.O. 1990, Regulation 1093, under the Veterinarians Act, R.S.O. 1990, c. V.3;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

  • On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

  • Has been found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Lalit Satija, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Medicare Pharmacy in Oakville, Ontario (“Medicare Oakville”), and/or director, shareholder, owner, designated manager, and/or dispensing pharmacist at Medicare Pharmacy in Brampton, Ontario (“Medicare Brampton”), committed professional misconduct in that he:

  • Failed to conduct, and/or maintain a record of, adequate inventory counts and/or reconciliations for narcotics and/or other controlled substances and/or to report losses to Health Canada as required from in or about January 2017 to in or about December 2018;
  • Submitted false claims, falsified records, and/or failed to keep records as required with respect to approximately 51 claims for MedsCheck reviews between in or about November 2017 and in or about December 2018;
  • Submitted claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about January 2018 to in or about March 2019;
  • Failed to dispose of expired medications and/or failed to have adequate systems in place to ensure expired medications were removed from stock from in or about August 2018 to in or about December 2018;
  • Returned to stock, resold, and/or re-dispensed a drug that was previously sold or dispensed, with respect to one or more of certain identified prescriptions from in or about July 2017 to in or about March 2019;
  • Failed to cancel prescriptions that were returned to stock, resold, and/or re-dispensed, with respect to one or more of certain identified prescriptions from in or about July 2017 to in or about March 2019;
  • Dispensed medications without accurately recording the Drug Identification Number and/or the identity of the manufacturer on the prescription hardcopy, label, and/or in the pharmacy’s electronic records from in or about July 2018 to in or about December 2018;
  • Requested, accepted, and/or failed to repay loans to patients from in or about 2012 to in or about 2019; and/or
  • Charged the credit card of a patient without the patient’s authorization from in or about December 2012 to in or about March 2017.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
    • sections 42 and/or 43 of the Narcotic Control Regulations, as amended, and/or
    • section 7 of the Benzodiazepines and Other Targeted Substances Regulations, as amended;
  • Returned to stock, resold, and/or re-dispensed a drug that was previously sold or dispensed;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist in Ottawa, Ontario, committed professional misconduct in that he

  • Engaged in the trafficking of controlled substance with respect to certain identified items
  • Dispensed drugs and/or products for which prescriptions are legislatively required without an authorized prescriber’s authorization as set out for certain identified items
  • In or about the period from January 2013 to March 2015, he failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs
  • Submitted accounts or charges for services that he knew were false or misleading to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
  • Falsified pharmacy records relating to his practice in relation to claims made to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
  • From approximately January 2013 to March 2015, he used his position as pharmacist to traffic in narcotics, in particular fentanyl patches
  • Procured an individual to carry out a simulated robbery of the IDA Rideau Pharmacy on October 26, 2014
  • Made a report to the […] Police in respect of a robbery allegedly committed on October 26, 2014, knowing that the report was false

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his patients
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement with respect to the certain identified forged prescriptions
  • Submitted accounts or charges for services that he knew to be false or misleading
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts with respect to the following incidents:
    • Dispensing drugs and/or products in the absence of a prescription authorized by a prescriber in contravention of s. 40 of Ontario Regulation 58/11 under the Drug and Pharmacies Regulation Act and ss. 155 and 156
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, with respect to the following incidents:
    • Trafficking controlled substances in contravention of s. 5 of the Controlled Drugs and Substances Act
    • Dispensing drugs in the absence of a prescription authorized by a prescriber in contravention of s. 31 of the Narcotic Control Regulation
    • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of C.01.041 of the Food and Drug Regulations
    • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of G.03.002 of the Food and Drug Regulations
  • Knowingly permitted the premises in which the pharmacy was located to be used for unlawful purposes
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen committed professional misconduct in that he

  • Failed to comply with the decision of the Inquiries, Complaints and Reports Committee dated May 10, 2016, in that he failed to successfully complete the Professional Problem-Based Ethics workshop offered by the Center for Personalized Education for Physicians, at his own expense, within 12 months of the date of that decision, and provide proof thereof to the College.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, namely: he contravened s. 26(3) of the Health Professions Procedural Code
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at IDA Rideau Medical Pharmacy in Ottawa, Ontario, between May 2, 2011 and June 17, 2015, committed professional misconduct in that he

  • Falsified pharmacy records relating to his practice in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
  • Submitted an account or charge for services that he knew was false or misleading in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified pharmacy records relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shani-Abbas Siwani, as a dispensing pharmacist and/or Designated Manager at Pharmalinx Guardian Pharmacy at 2101 Brimley Road in Toronto, Ontario (the Pharmacy), and/or as the sole director and/or a shareholder of the corporation that owned the Pharmacy, committed professional misconduct with respect to false or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $1,142,375.55 between May 1, 2017 and March 31, 2019 for 17 identified drugs, or any of them.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6, and 15 of the Ontario Drug Benefit Act;
  • Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Adel Soliman, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Westown Pharmacy on Dixon Road in Toronto, Ontario, from about December 1, 2015 to May 28, 2019, committed professional misconduct in that he:

  • Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Falsified records relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, ss. 5 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sameh Yassa, as pharmacist and/or Designated Manager of Downtown Dispensary located at 188 Mississauga Street, in Orillia, Ontario (the “Pharmacy”) and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he:

  • Failed to adequately document Pharmacy patients’ missed doses of methadone and/or buprenorphine, from on or about October 22, 2018, to on or about February 14, 2020; and/or
  • Failed to document notification of Pharmacy patients’ prescribers of missed patient doses of methadone and/or buprenorphine as required, from on or about October 22, 2018, to on or about February 14, 2020; and/or
  • Maintained incomplete and/or inaccurate records with respect to prescriptions billed for patients [Patient 1] and/or [Patient 4], from on or about January 18, 2020, to on or about February 14, 2020; and/or
  • Failed to maintain records of Methadose sign-in/observed-dose sheets for certain identified patients, from on or about January 1, 2018, to on or about February 14, 2020.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Syed Zaidi committed professional misconduct in that:

  • He engaged in assault on or around December 14, 2015, which is an offence under section 266 of the Criminal Code, and in the conduct and acts which form the basis of this criminal conviction;
  • He failed to report to the College’s Registrar two criminal charges laid against him, as set out in the information sworn on or about August 27, 2015, as required by s. 5(1) of Ontario Regulation 202/94 under the Pharmacy Act, 1991, within 30 days as required by College By-Laws;
  • He failed to report to the College’s Registrar two criminal charges laid against him on or around March 18, 2018, as required by s. 5(1) of Ontario Regulation 202/94 under the Pharmacy Act, 1991, within 30 days as required by College By-Laws;
  • On or around August 30, 2019, he was found guilty of one count of assault, which is an offence contrary to section 266 of the Criminal Code.

In particular, it is alleged that he:

  • Was found guilty of an offence that is relevant to his suitability to practice;
  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.